Livemint

Mutual fund returns 2026: Pharma, small-cap funds outperform as last year's winners stumble

A sharp reversal has reshaped the mutual fund leaderboard in 2026, with many of last year's best-performing categories slipping. Here's what the latest data shows and why experts say investors should avoid chasing past returns.